HolderBook

FREELINE THERAPEUTICS HLDGS (FRLN)

Institutional ownership reported to the SEC as of Q4 2023, across 14 quarters.

14
Reporting holders
$12.9M
Reported value
0.0%
Held as options
+3
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
Syncona Portfolio Ltd$9.3M1,466,5075.91%9qHELD
JPMORGAN CHASE & CO$852.9K134,1060.00%newNEW
UBS Group AG$632.9K99,3580.00%3q+190.5%+$415.0K
Blue Owl Capital Holdings LP$552.0K86,6540.13%newNEW
MORGAN STANLEY$544.7K85,5140.00%3q+101.5%+$274.4K
PenderFund Capital Management Ltd.$509.0K60,4010.17%newNEW
HARBOR CAPITAL ADVISORS, INC.$129.4K20,3520.02%3q+62.8%+$49.9K
SPHERA FUNDS MANAGEMENT LTD.$104.8K16,4450.02%newNEW
NORTHERN TRUST CORP$99.7K15,6590.00%3qHELD
49 WEALTH MANAGEMENT, LLC$98.9K15,5190.03%newFIRST
RHUMBLINE ADVISERS$9851550.00%2q+34.8%
Gradient Investments LLC$6371000.00%newNEW
Aspire Private Capital, LLC$509800.00%3qHELD
RENAISSANCE TECHNOLOGIES LLC$22034,4600.00%3q+30.7%
Qube Research & Technologies Ltd$2540.00%2qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q4 202314$12.9M2,000,8545400.0%
Q3 202311$9.8M2,295,3703400.0%
Q2 20239$5.0M1,949,4838010.0%
Q1 202311$16.7M36,418,0450160.0%
Q4 202212$18.0M37,729,0022120.0%
Q3 202213$26.4M37,948,2851250.0%
Q2 202216$33.2M37,990,8661540.0%
Q1 202218$21.3M35,892,23751110.0%
Q4 202118$26.0M13,200,5100750.0%
Q3 202120$36.1M10,611,1629530.0%
Q2 202116$96.2M11,859,2331360.0%
Q1 202119$144.0M11,770,3090250.0%
Q4 202020$216.6M11,923,6782670.0%
Q3 202022$154.8M9,975,30922000.0%